ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

Funding Opportunity: EPA, NIEHS Set Aside $10M For Research On Disease Prevention In Children

September 19, 1997

Yarbro-Chabner Debate Continues

April 29, 1983

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978